Results 21 to 30 of about 120,194 (305)

Standing Vigil for the Day to Come

, 2015
Michel Foucault’s “Standing Vigil for the Day to Come” was a review of Roger Laporte’s novel, La Veille, published by Gallimard earlier that year. Although Laporte’s work never received the wide readership it deserved, Foucault held it in high esteem ...
Elise Woodard, Robert Harvey
openalex   +2 more sources

Phase 1, First-In-Human, Single-/Multiple-Ascending Dose Study of Iluzanebart in Healthy Volunteers. [PDF]

Ann Clin Transl Neurol
Objective To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of iluzanebart, a fully human monoclonal antibody TREM2 (triggering receptor expressed on myeloid cells 2) agonist, after single‐ (SAD) and multiple‐ascending‐dose ...
Meier A, Papapetropoulos S, Marsh A, Neelon K, Stiles D, O'Mara R, Thackaberry EA, Colonna M, Rajagovindan R.   +8 more
europepmc   +2 more sources

Vigil [PDF]

Journal of General Internal Medicine, 2019
Jason Young
openaire   +3 more sources

Relevance of new scientific information (Santos‐Vigil et al., 2018[Link]) in relation to the risk assessment of genetically modified crops with Cry1Ac [PDF]

EFSA Supporting Publications, 2018
Antonio Fernández Dumont, Anna Lanzoni, Elisabeth Waigmann, Claudia Paoletti   +3 more
openalex   +2 more sources

The Vigil of Medicine

International Journal of Medical Students, 2021
Kiersten Kelly
openaire   +5 more sources

Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA

Clinical Cancer Research, 2023
Purpose: Treatment options for recurrent or refractory Ewing's sarcoma (ES) are limited. Vigil is a novel autologous tumor cell therapy expressing bi-shRNA furin/GMCSF plasmid, which previously demonstrated monotherapy activity in advanced ES.
P. Anderson, Maurizio Ghisoli, B. Crompton, K. Klega, L. Wexler, E. Slotkin, L. Stanbery, L. Manning, G. Wallraven, Meghan Manley, S. Horvath, E. Bognar, J. Nemunaitis   +12 more
semanticscholar   +1 more source

Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars

Journal of Cannabis Research, 2023
Background Little is known about the frequency with which different combinations of phytochemicals (chemovars) arise in Cannabis flower or whether common chemovars are associated with distinct pharmacodynamics and patient health outcomes.
J. Vigil, Sarah S. Stith, Franco Brockelman, Keenan Keeling, Branden Hall   +4 more
semanticscholar   +1 more source

3D engineered scaffold for large-scale Vigil immunotherapy production. [PDF]

Sci Rep
Previously, we reported successful cellular expansion of a murine colorectal carcinoma cell line (CT-26) using a three-dimensional (3D) engineered extracellular matrix (EECM) fibrillar scaffold structure.
Kerneis F, Bognar E, Stanbery L, Moon S, Kim DH, Deng Y, Hughes E, Chun TH, Tharp D, Zupanc H, Jay C, Walter A, Nemunaitis J, Lahann J.   +13 more
europepmc   +2 more sources

Real Time Vigilance Detection using Frontal EEG [PDF]

International Journal of Computer Science & Information Technology (IJCSIT) Vol 13, No 1, February 2021, 2021
Vigilance of an operator is compromised in performing many monotonous activities like workshop and manufacturing floor tasks, driving, night shift workers, flying, and in general any activity which requires keen attention of an individual over prolonged periods of time.
arxiv   +1 more source

‘It’s Not Like in the Films’: Bereaved People’s Experiences of the Deathbed Vigil

Omega, 2022
This paper explores how people enact and experience the deathbed vigil when someone close to them is dying. It draws on qualitative interviews with 34 bereaved people carried out as part of a wider study exploring public perceptions of death and dying ...
G. Caswell, E. Wilson, Nicol E. Turner, K. Pollock   +3 more
semanticscholar   +1 more source